Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 206,535 | 20,291 | 125,806 | 28,193 | 24,869 |
| Marketable Securities | 187,720 | 115,194 | 60,729 | 118,130 | 166,076 |
| Receivables | N/A | N/A | N/A | N/A | 687 |
| TOTAL | $403,802 | $138,073 | $191,099 | $151,585 | $202,923 |
| Non-Current Assets | |||||
| PPE Net | 465 | 701 | 1,178 | 1,761 | 2,409 |
| Investments And Advances | 21,932 | 0 | 8,067 | 0 | 0 |
| Other Non-Current Assets | 8,487 | 3,078 | 1,974 | 479 | 395 |
| TOTAL | $30,884 | $3,779 | $11,219 | $2,240 | $2,804 |
| Total Assets | $434,686 | $141,852 | $202,318 | $153,825 | $205,727 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,828 | 1,096 | 2,728 | 231 | 2,503 |
| Accrued Expenses | 21,326 | 14,345 | 9,752 | 4,698 | 12,411 |
| Other current liabilities | 10,000 | N/A | N/A | N/A | N/A |
| TOTAL | $36,843 | $15,441 | $18,366 | $9,857 | $17,636 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,689 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 104,487 | 90,257 | 51,015 | 1,262 | 1,743 |
| TOTAL | $105,587 | $90,257 | $51,015 | $1,262 | $1,743 |
| Total Liabilities | $142,430 | $105,698 | $69,381 | $11,119 | $19,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,724 | 97,293 | 84,678 | 68,946 | 68,882 |
| Common Shares | 11 | 8 | 8 | 7 | 7 |
| Retained earnings | -978,227 | -872,857 | -766,856 | -676,858 | -625,872 |
| Other shareholders' equity | 144 | -326 | -13 | 8 | 80 |
| TOTAL | $292,256 | $36,154 | $132,937 | $142,706 | $186,348 |
| Total Liabilities And Equity | $434,686 | $141,852 | $202,318 | $153,825 | $205,727 |